Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

180 Life Sciences Corp, after significant losses, plans to invest in Ether and rebrand as ETHZilla Corporation. Raising $425 million through a PIPE deal, the company aims to create a treasury reserve of ETH.

The firm reported an accumulated deficit of over $141.5 million and is part of a broader trend where penny stocks are pivoting to cryptocurrencies in search of financial recovery as traditional revenue streams decline.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts